SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549

                                    FORM 10-Q


                 QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended              October 30, 1999
Commission File Number             0-3319

                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


          New York                                               13-1784308
          --------                                               ----------
(State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                               Identification No.)

One Commerce Park, Valhalla, NY                                    10595
-------------------------------                                    -----
(Address of principal executive offices)                         (Zip Code)


                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the business on December 8,1999.



                            Common Stock - 7,814,916




<PAGE>






                                     PART I


Item 1.  Financial Statements

              Consolidated Balance Sheets - October 30, 1999 and July 31, 1999

              Consolidated  Statements  of  Income  for the Three  Months  ended
              October 30, 1999 and October 31, 1998

              Consolidated  Statements  of Cash Flows for the Three Months ended
              October 30, 1999 and October 31, 1998

              Notes to Consolidated Financial Statements


































                                      -1-
<PAGE>




                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)


                                     ASSETS
                                                       October 30,     July 31,
                                                          1999           1999
                                                      -----------    -----------
CURRENT ASSETS
   Cash and cash equivalents                          $   626,113    $   320,742
   Investments available-for-sale                       1,139,370      1,292,852
   Trade receivables - net                             14,912,641     15,624,433
   Cost and estimated earnings in excess of
      billings on uncompleted contracts                 7,759,094      6,402,532
   Inventory                                           37,212,350     36,599,587
   Prepaid expenses and other current assets            1,576,066      1,216,145
                                                      -----------    -----------
              Total current assets                     63,225,634     61,456,291
                                                      -----------    -----------

FIXED ASSETS - Net                                     14,975,212     14,668,060
INTANGIBLES - Net                                         834,191        879,898
GOODWILL - Net                                          5,164,082      5,236,965
DEFERRED CHARGES                                          231,873        264,464
OTHER ASSETS                                            1,613,763      1,598,279
                                                      -----------    -----------
         TOTAL                                        $86,044,755    $84,103,957
                                                      ===========    ===========


                      LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES
   Current portion of long-term debt                  $   784,467    $   516,654
   Accounts payable - trade                             6,255,667      6,295,586
   Accrued liabilities                                  4,556,690      4,468,521
   Deferred compensation liability                      1,209,321      1,201,065
   Income taxes                                         1,114,894      1,224,451
                                                      -----------    -----------
              Total current liabilities                13,921,039     13,706,277
                                                      -----------    -----------

LONG-TERM LIABILITIES
   LONG-TERM DEBT (less current portion
      included above)                                   2,078,832      1,832,287
   OTHER                                                  573,505        594,272
   DEFERRED INCOME TAXES                                1,778,442      1,620,417
                                                      -----------    -----------
              Total liabilities                        18,351,818     17,753,253
                                                      -----------    -----------

SHAREHOLDERS' EQUITY
   Common stock, $.10 par value;
      Authorized 20,000,000 shares;
      Issued and  outstanding 8,354,316
      shares at October 30, 1999 and
      8,278,646 shares at July 31, 1999                   835,433        827,866
   Additional paid-in capital                          51,058,863     50,798,502
   Retained earnings                                   20,558,485     19,032,506
                                                      -----------    -----------
                                                       72,452,781     70,658,874
   Less common stock in treasury -
      546,261 shares at October 30, 1999
      and 490,393 shares at July 31, 1999               4,759,844      4,308,170
                                                      -----------    -----------
              Total shareholders' equity               67,692,937     66,350,704
                                                      -----------    -----------
         TOTAL                                        $86,044,755    $84,103,957
                                                      ===========    ===========

    See notes to consolidated financial statements

                                      -2-
<PAGE>


                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)


                                                          Three Months Ended
                                                     ---------------------------
                                                     October 30,     October 31,
                                                        1999            1998
                                                     -----------     -----------

NET SALES                                            $15,712,024     $14,809,666
                                                     -----------     -----------
COSTS AND EXPENSES:
     Cost of sales                                     9,310,733       8,679,168
     Research and development                          1,543,154       1,431,314
     Selling, general and administrative               2,603,174       2,621,162
     Interest expense - net                               62,037
                                                     -----------     -----------
                                                                           6,881
                                                      13,519,098      12,738,525
INCOME BEFORE PROVISION
     FOR INCOME TAXES                                  2,192,926       2,071,141

PROVISION FOR INCOME TAXES                               666,948         642,054
                                                     -----------     -----------
NET INCOME                                           $ 1,525,978     $ 1,429,087
                                                     ===========     ===========

NET INCOME PER COMMON SHARE AND
     COMMON SHARE EQUIVALENTS:

     BASIC                                           $       .20     $       .19
                                                     ===========     ===========
     DILUTED                                         $       .19     $       .18
                                                     ===========     ===========

Weighted number of common
      shares outstanding                               7,786,004       7,648,413
                                                     ===========     ===========


Weighted number of common
      shares and common share
      equivalents outstanding                          8,171,777       8,142,557
                                                     ===========     ===========


See notes to consolidated financial statements




                                      -3-
<PAGE>




                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)




                                                         Three Months Ended
                                                      --------------------------
                                                      October 30,    October 31,
                                                         1999           1998
                                                      -----------   ------------
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net Income                                         $ 1,525,978   $ 1,429,087
   Adjustments to reconcile net income to net
   cash provided by operating activities:
     Depreciation                                         555,560       413,419
     Amortization                                         187,462       157,944
     Imputed interest                                      19,706        10,974
     Deferred income tax provision                        147,495        94,745
     Tax benefit from exercise of stock options
       and warrants                                       188,849        18,019
     Amortization of stock-based compensation               7,833         5,508
   Changes in assets and liabilities:
      Decrease (increase) in trade receivables            711,792      (869,725)
      Increase in cost and estimated earnings in
        excess of billings on uncompleted contracts    (1,356,562)     (908,225)
      Increase in inventory                              (612,763)   (2,072,986)
      Increase in prepaid and other current assets       (396,202)     (539,657)
      Increase in other assets                             (4,954)       (6,776)
      (Decrease) increase in accounts payable - trade     (39,919)    1,170,993
      Increase in accrued liabilities                      85,072       145,842
      Increase in deferred compensation liability           8,256        69,902
      (Decrease) increase in income taxes payable        (109,557)      378,790
                                                      -----------   -----------
Net cash provided by (used in) operating activities       918,046      (502,146)
                                                      -----------   -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
   Expenditures for fixed assets                         (862,712)     (692,266)
   Investment in marketable securities                    153,482       (73,026)
   Payments to former shareholders of subsidiary
     acquired                                             (17,707)      (29,796)
                                                      -----------   -----------
Net cash used in investing activities                    (726,937)     (795,088)
                                                      -----------   -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
   Net proceeds from bank borrowing                       514,358       498,737
   Payment for repurchase of shares                      (451,674)     (682,404)
   Proceeds from exercise of stock options and
     warrants                                              71,247        42,548
   Other                                                  (19,669)       (5,784)
                                                      -----------   -----------
Net cash provided by (used in) financing activities       114,262      (146,903)
                                                      -----------   -----------

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS      305,371    (1,444,137)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD            320,742     3,401,697
                                                      -----------   -----------

CASH AND CASH EQUIVALENTS, END OF PERIOD              $   626,113   $ 1,957,560
                                                      ===========   ===========

See notes to consolidated financial statements





                                      -4-
<PAGE>


                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)

                                                           Three Months Ended
                                                      --------------------------
                                                      October 30,    October 31,
                                                         1999           1998
                                                      -----------   ------------


SUPPLEMENTAL DISCLOSURES OF CASH FLOW
             INFORMATION:

             Interest paid                            $     6,359    $   33,724
                                                      ===========    ==========
             Income taxes paid                        $   482,440    $  150,500
                                                      ===========    ==========






See notes to consolidated financial statements






















                                      -5-
<PAGE>




                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                   (Unaudited)



NOTE 1   In the opinion of the Company's management,  the accompanying unaudited
         consolidated  financial statements contain all adjustments  (consisting
         of only normal recurring  adjustments)  necessary to present fairly the
         results of the Company's  financial position as of October 30, 1999 and
         the results of its  operations  and its cash flows for the three months
         ended October 30, 1999 and October 31, 1998.

         The accounting policies followed by the Company are set forth in Note 1
         to the Company's financial statements as of July 31, 1999.

         The  consolidated  financial  statements  should be read in conjunction
         with the notes to the financial statements as of July 31, 1999.

         Certain   reclassifications  have  been  made  in  the  prior  period's
         financial   statements   to   correspond   to  the   current   period's
         presentation.


NOTE 2   The results of operations for the three-month  period ended October 30,
         1999 are not  necessarily  indicative of the results to be expected for
         the full year.


NOTE 3   INVESTMENTS

         Investments  available-for-sale  at October  30, 1999 and July 31, 1999
         include  $1,209,321and  $1,201,065,  respectively,  for  the  Company's
         President's  deferred  compensation  and  certain  key  executives.  At
         October  30,  1999  and  July  31,   1999,   $118,514   and   $213,411,
         respectively,  were  classified  as cash and  $1,090,808  and $987,654,
         respectively,   were  recorded  as  investments.   The  liabilities  of
         $1,209,321  and  $1,201,065,  respectively,  are  recorded  as deferred
         compensation  liability.  Gains and losses on the  investments  held to
         fund the deferred compensation,  either recognized or unrealized, inure
         to the  benefit or  detriment  of the  President's  or key  executives'
         deferred compensation.  At October 30, 1999, the balance of investments
         available-for-sale of $48,562 are equity securities held by the Company
         for its own account.  Realized and unrealized gains and losses on these
         securities  for the period ended October 30, 1999 were not material and
         are recorded in the financial statements.


NOTE 4   PERCENTAGE OF COMPLETION ACCOUNTING


                                                        October 30,    July 31,
                                                           1999          1999
                                                        -----------  -----------
         Costs incurred on uncompleted
            contracts                                  $15,206,728   $15,012,158

         Estimated earnings                              9,906,018     9,329,220
                                                       -----------   -----------
                                                        25,112,746    24,341,378

         Less billings to date                          17,353,652    17,938,846
                                                       -----------   -----------
         Costs and estimated earnings
            in excess of billings on
            uncompleted contracts                      $ 7,759,094   $ 6,402,532
                                                       ===========   ===========

         The  backlog  of  unshipped  contracts  being  accounted  for under the
         percentage of completion  method of accounting was  approximately  $4.7
         million at October 30, 1999.


                                      -6-
<PAGE>


NOTE 5   INVENTORY

         Inventory  is  stated  at the lower of cost  (first-in,  first-out)  or
         market.

         Inventories  and  their  effect  on cost of  sales  are  determined  by
         physical  count for annual  reporting  purposes  and are  estimated  by
         management for interim reporting purposes.

               Inventory consists of the following:
                                                        October 30,    July 31,
                                                           1999          1999
                                                        -----------  -----------

         Finished goods                                 $ 7,820,260  $ 5,414,095
         Work-in-process                                 17,246,575   14,814,766
         Raw material and purchased parts                12,145,515   16,370,726
                                                        -----------  -----------

         Total                                          $37,212,350  $36,599,587
                                                        ===========  ===========


NOTE 6   FIXED ASSETS

         Fixed assets consist of the following:
                                                        October 30,    July 31,
                                                           1999          1999
                                                        -----------  -----------
         Land                                           $   694,046  $   694,046
         Building                                         2,178,025    2,161,025
         Machinery and equipment                         16,520,067   15,967,619
         Furniture and fixtures                           2,021,237    1,914,396
         Leasehold improvements                           2,367,296    2,180,873
         Transportation equipment                            30,103       30,103
                                                        -----------  -----------
                                                         23,810,774   22,948,062

         Less accumulated depreciation and amortization   8,835,562    8,280,002
                                                        -----------  -----------

         Net fixed assets                               $14,975,212  $14,668,060
                                                        ===========  ===========


NOTE 7   SEGMENTS

         The Company  adopted SFAS No. 131,  "Disclosures  about  Segments of an
         Enterprise and Related  Information",  during the fourth quarter of the
         year  ended  July 31,  1999.  SFAS No. 131  establishes  standards  for
         reporting  information  about  operating  segments in annual  financial
         statements and requires selected  information about operating  segments
         in interim  financial  statements.  It also  establishes  standards for
         related  disclosures  about products and services,  major customers and
         geographic  areas.  Operating  segments are defined as components of an
         enterprise about which separate financial information is available that
         is evaluated  regularly by the chief decision maker, or decision making
         group,  in  deciding  how  to  allocate   resources  and  in  assessing
         performance.  The Company's  chief  operating  decision making group is
         comprised of the Chief Executive  Officer and the senior  executives of
         the Company's operating segments.

         The  Company has two  reportable  segments  which are  Medical  Imaging
         Systems and Critical Electronic Subsystems. The Medical Imaging Systems
         Segment   designs,    manufactures   and   markets    state-of-the-art,
         cost-effective  medical  imaging and diagnostic  systems  consisting of
         stationary  and  portable  imaging  systems,  radiographic/fluoroscopic
         systems,  mammography  systems  and a  neo-natal  imaging  system.  The
         Critical  Electronic  Subsystems  Segment  designs,   manufactures  and
         markets  proprietary  precision power conversion and noise  suppression
         subsystems for medical as well as critical industrial applications.

         Selected financial data of these segments is as follows:



                                      -7-
<PAGE>

<TABLE>
<CAPTION>
                                                          Medical     Critical
                                                          Imaging    Electronic
                                                          Systems    Subsystems      Total
                                                       ------------  -----------  -----------
         For the Three Months Ended October 30, 1999:

         <S>                                           <C>           <C>          <C>
         Net sales to external customers               $  7,883,898  $ 7,828,126  $15,712,024
                                                       ============  ===========  ===========
         Income before provision for income taxes      $    614,991  $ 1,577,935  $ 2,192,926
                                                       ============  ===========  ===========
         Segment assets                                $ 11,817,441  $74,227,314  $86,044,755
                                                       ============  ===========  ===========

</TABLE>
<TABLE>
<CAPTION>
                                                          Medical     Critical
                                                          Imaging    Electronic
                                                          Systems    Subsystems      Total
                                                       ------------  -----------  -----------
         For the Three Months Ended October 31, 1998:

         <S>                                           <C>           <C>          <C>
         Net sales to external customers               $  7,345,710  $ 7,463,956  $14,809,666
                                                       ============  ===========  ===========
         Income before provision for income taxes      $    611,836  $ 1,459,305  $ 2,071,141
                                                       ============  ===========  ===========
         Segment assets                                $  8,210,220  $67,293,568  $75,503,788
                                                       ============  ===========  ===========
</TABLE>



                                      -8-
<PAGE>


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

This  Management  Discussion and Analysis of Financial  Condition and Results of
Operations contains forward looking statements.  Such statements involve various
risks that may cause actual results to differ  materially.  These risks include,
but are not  limited to, the  ability of the  Company to grow  internally  or by
acquisition  and  to  integrate  acquired   businesses,   changing  industry  or
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.

OVERVIEW

                 The  Company's  net sales  have  increased  as a result of both
internal growth and acquisitions. The Company has completed five acquisitions in
the past six years:  Dynarad (a designer  and  manufacturer  of medical  imaging
systems and critical  electronic  subsystems) in fiscal 1993; Bertan (a designer
and  manufacturer  of precision high voltage power supplies and  instrumentation
for  medical  and  industrial   applications)  in  fiscal  1994;  Gendex-Del  (a
manufacturer of medical  imaging  systems) in fiscal 1996;  X-Ray  Technologies,
Inc.  (a  manufacturer  of medical  imaging  systems)  in fiscal  1998 and Acoma
Medical Imaging Inc. (a designer and manufacturer of medical imaging systems) in
fiscal 1999.

                 During the past five years the Company has grown internally and
through  acquisitions into a company whose  predominant  business is serving the
medical imaging and diagnostic markets.  The Company's net sales attributable to
medical imaging products have increased from approximately  $14.4 million or 44%
of total net sales in fiscal 1995 to approximately $49.2 million or 72% of total
net sales in fiscal 1999.

                 Management  believes that recent cost containment trends in the
healthcare  industry have created  opportunities for its cost-effective  medical
imaging products in domestic and international markets. Some of these trends are
increased  demand for lower cost medical  equipment,  the outsourcing of systems
and critical electronic  subsystems by leading original equipment  manufacturers
("OEMs"),  increased  demand for certain  diagnostic  procedures  and lower cost
medical services in the global marketplace.

RESULTS OF OPERATIONS

                 Net sales for the three  months  ended  October  30,  1999 were
approximately  $15.7 million as compared to approximately  $14.8 million for the
three months ended October 31, 1998, an increase of 6.1%. The increase is due to
internal growth from existing operations.

                 Cost of  sales,  as a  percentage  of net  sales  for the three
months  ended  October  30,  1999,  was  59.3%  compared  to 58.6% for the prior
corresponding  period.  This  decrease in gross  margins is due to the change in
product mix in the period.

                 Research and development  expenses  increased to  approximately
$1.5 million for the three months ended October 30, 1999 from approximately $1.4
million for the three months ended  October 31, 1998,  an increase of 7.8%.  The
increase was primarily due to new product development.  The Company continues to
invest in research and  development  in order to introduce new  state-of-the-art
products for its medical and industrial markets.

                 Selling, general and administrative expenses were approximately
$2.6 million, or 16.6% of net sales, for the three months ended October 30, 1999
as compared to approximately  $2.6 million,  or 17.7% of net sales, for the same
period in the prior year, a decrease of 0.7%.

                 Net interest  expense was  approximately  $62,000 for the three
months  ended  October  30, 1999 as  compared  to  approximately  $7,000 for the
corresponding period in the prior year. This increase is due to higher levels of
long-term debt for the quarter.

                 Income  tax  expense  was 30.4% of pretax  income for the three
months ended  October 30, 1999 and 31% for the three  months  ended  October 31,
1998.  The decrease  from  statutory  rates is primarily due to sales being made
through the Company's  Foreign Sales  Corporation,  research and development and
other tax credits.

                 Net income  increased  to  approximately  $1.5  million for the
three months ended October 30, 1999, an increase of 6.8% from approximately $1.4
million for the prior corresponding  period. Basic earnings per share at October
30, 1999  increased to $.20 from $.19 at October 31, 1998,  an increase of 4.9%.
Diluted  earnings  per share  increased to $.19 at October 30, 1999 from $.18 at
October 31,  1998,  an increase of 6.4%.  The weighted  number

                                      -9-
<PAGE>
of common  shares  outstanding  increased  to 7,786,004 at October 30, 1999 from
7,648,413  at October 31, 1998 and the number of common  shares and common share
equivalents  outstanding  increased  to  8,171,777  at  October  30,  1999  from
8,142,557  at October 31, 1998.  The increase in net income for the  three-month
period ended October 30, 1999 is primarily due to higher sales.

                 The  backlog  of  unshipped  orders  at  October  30,  1999 was
approximately $39 million.

LIQUIDITY AND CAPITAL RESOURCES

                 The Company has funded its operations and acquisitions  through
a combination of cash flow from  operations,  bank borrowing and the issuance of
the Company's common stock.

                 Working  Capital.  At October 30, 1999 and July 31,  1999,  the
Company's  working  capital was  approximately  $49.3 million and $47.8 million,
respectively. At such dates the Company had approximately $626,000 and $321,000,
respectively, in cash and cash equivalents.

                 Trade  receivables at October 30, 1999 decreased  approximately
$712,000 as compared to July 31, 1999,  primarily due to lower revenue levels in
the  three-month  period ended  October 30, 1999 as compared to the  three-month
period ended July 31, 1999.

                 Cost  and   estimated   earnings   in  excess  of  billings  on
uncompleted  contracts  increased to  approximately  $7.8 million at October 30,
1999 from  approximately  $6.4 million at July 31, 1999 due to  additional  work
performed  in the  quarter  on  long-term  contracts  accounted  for  under  the
percentage of completion method of accounting.

                 Inventory at October 30, 1999 increased  approximately $613,000
as  compared  to July  31,  1999  primarily  because  of  additional  production
requirements of major medical OEM contracts.

                 Prepaid  expenses and other current  assets at October 30, 1999
increased  approximately $360,000 as compared to July 31, 1999 due to additional
prepaid expenses related to increased acquisition activity.

                 Credit Facility and Borrowing.  At October 30, 1999 the Company
had a $14.0 million revolving credit line and a $10.0 million acquisition credit
line. The available portion of the revolving credit line was approximately $12.7
million,  after deducting outstanding letters of credit of approximately $15,000
and $8.6 million was available under its acquisition credit line.

                 Capital  Expenditures.  The  Company  continues  to  invest  in
capital  equipment,  principally for its manufacturing  operations,  in order to
improve its  manufacturing  capability  and  capacity.  The Company has expended
approximately  $863,000 for capital  equipment for the three-month  period ended
October 30, 1999.

                 The Company anticipates that cash generated from operations and
amounts  available  under its bank  lending  facilities  will be  sufficient  to
satisfy its currently projected operating cash needs.

                 Shareholders'   Equity.   Shareholders'   equity  increased  to
approximately $67.7 million at October 30, 1999 from approximately $66.4 million
at July 31,  1999,  primarily  due to the results of  operations.  Additionally,
during the period 75,670 stock options were exercised,  with proceeds of $71,247
and 48,775 shares of common stock were repurchased at a cost of $383,192.

                 Year 2000. The Company has initiated a company-wide program and
developed a formal plan to identify, evaluate and implement changes to products,
computer systems,  applications and  infrastructure  necessary to achieve a year
2000 date  conversion  with no effect on  customers  or  disruption  to business
operations.  These actions are necessary to ensure that all systems and business
applications will recognize and process the year 2000 and beyond.

                 The Company uses purchased  software  programs for a variety of
functions,  including drafting and design,  general accounting and manufacturing
applications.  Currently,  all of the Company's products and software for design
and drafting applications are fully compliant. The Company's systems for general
accounting and manufacturing have been evaluated and steps to achieve compliance
have been implemented and these systems are expected to be fully  compliant.  At
this  time,   the  Company   believes   that  it  does  not  have  any  internal
mission-critical year 2000 issues that it cannot remedy.

                                      -10-
<PAGE>

                 As  part  of  the  year  2000  readiness  process,  significant
customers,  service  providers,  vendors and  suppliers  who are  believed to be
crucial to business  operations  after January 1, 2000 have been  identified and
steps  have  been   taken  to   ascertain   their   state  of   readiness.   All
mission-critical third parties have indicated that they are or will be year 2000
compliant.   The  Company  has   surveyed   them   primarily   through   written
correspondence. Despite its efforts to ascertain the readiness of its customers,
suppliers and service providers,  the Company cannot be certain as to the actual
year 2000 readiness of these third parties or the impact their noncompliance may
have on the Company's future financial  position,  the results of its operations
or its cash flows.

                 With respect to the Company's  internal  year 2000  compliance,
the Company has incurred  internal staff costs,  as well as consulting and other
expenses  and the total  costs  incurred  for all year 2000  compliance  related
projects did not have a material  effect on the  Company's  financial  position,
results of its operations or its cash flows.

EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS

                 Disclosures   about   Derivative    Instruments   and   Hedging
Activities.  In June  1998,  the FASB  issued  SFAS  No.  133,  "Accounting  for
Derivative  Instruments  and  Hedging  Activities."  SFAS  No.  133  establishes
accounting  and  reporting  standards  for  derivative  instruments  and hedging
activities.  SFAS No. 133 is  effective  for all fiscal  years  beginning  after
December 15, 1999.  Management does not anticipate that this statement will have
any affect on the Company's consolidated financial statements.

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

                 Not applicable.

                                      -11-
<PAGE>


                                     PART II

Item 1.        Legal Proceedings

                   None


Item 2.        Changes in Securities

                   None


Item 3.        Defaults on Senior Securities

                   None


Item 4.        Submission to a Vote of Security Holders

                   None


Item 5.        Other Information

                   None


Item 6.        Exhibits and Reports on Form 8-K

               (a) Exhibits:  Exhibit 11 - Computation  of  Earnings  per Common
                              Share
                              Exhibit 27 - Financial Data Schedule

               (b) Report on Form 8-K:   None


                                      -12-
<PAGE>


                                   SIGNATURES


        Pursuant to the requirements of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.










                                              DEL GLOBAL TECHNOLOGIES CORP.




                                              /S/LEONARD A. TRUGMAN
                                              ---------------------
                                              Leonard A. Trugman
                                              Chairman of the Board,
                                              Chief Executive Officer
                                              and President




                                              /S/MICHAEL H. TABER
                                              ---------------------
                                              Michael H. Taber
                                              Chief Financial Officer,
                                              Vice President of Finance
                                              and Secretary



Dated:  December 9, 1999






                                      -13-